BeiGene nets $750m from ADS follow-on
Chinese biopharmaceutical company BeiGene wrapped up a follow-on offering of its Nasdaq-listed American Depository Shares on Wednesday, raising a larger than expected $750m, according to a company statement.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: